Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion evidence source_evidence_curated NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion SIO_000772 19204207 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion wasDerivedFrom ctd_human-2016 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion wasGeneratedBy ECO_0000218 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- ctd_human-2016 importedOn "2016-01-25" NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.